ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Atrium Medical

Atrium Medical Corporation is a relatively new medical device manufacturer. It’s based in the U.S., but it sells critical care products worldwide. Atrium is well-known for its soft tissue and hernia repair products. It also makes coronary and peripheral stents and catheters. Atrium operates as a subsidiary of Maquet. Swedish medical technology company Getinge Group owns Maquet.

Atrium Medical Corporation makes popular products like C-QUR mesh. It also makes vascular grafts, local therapeutic infusion catheters and covered stents.

Atrium Medical had stop manufacturing some of these products while it made corrections. Other products were restricted. But people could still get them with a certificate of medical necessity form.

In early 2015, Atrium signed a Consent Decree with the U.S. Food and Drug Administration. The decree established a framework that provided assurances to the FDA that the company would complete necessary improvements to strengthen its quality management system.

In 2018, Atrium recalled 60 units of ProLite Mesh for improper labeling. And as of October 2020, the company faces 2,378 hernia mesh lawsuits for its C-QUR mesh.

About Atrium

Atrium Medical’s headquarters is in Merrimack, New Hampshire. Atrium develops over 2.7 million medical products each year. It distributes them to over 60 countries.

Atrium History

Atrium Medical started in 1981. It has operated as a subsidiary of Maquet Cardiovascular LLC since November 2011, according to Bloomberg.

Maquet has German roots dating back to 1838. Getinge Group acquired Macquet in 2000. Getinge is a Swedish company.

Getinge brought in about $2.6 billion in revenue in 2017. MPO Magazine ranked Getinge No. 25 out of the top 30 medical device companies.

Mattias Perjos is Getinge’s current president and CEO. Carl Bennett is the company’s current chairman.

Hernia Mesh and Other Products

Atrium chest drainage device
Atrium leads the market in chest drainage devices.

Atrium develops products for cardiovascular disease, soft tissue repair and critical care management.

These products include artificial heart components, minimally invasive gastrointestinal devices, various catheters and stents, and soft tissue and hernia repair and support components.

The company also leads the market in chest drainage devices.

Some of Atrium’s popular products include:
C-Qur Mesh
Polypropylene mesh with Omega 3 gel coating
ProLoop Mesh Plug
3-dimensional plug
ProLite Mesh
2-dimensional flexible mesh
Clearway RX
Therapeutic infusion catheter
Xpress-Way RX
Extraction catheter
Drug eluting coronary stent system
Balloon expandable covered stent
Advanta V12
Balloon expandable PTFE film covered stent
3-layer vascular grafts

Defective Hernia Mesh Lawsuits

Atrium C-QUR mesh
Lawsuits blame Atrium C-QUR mesh for serious complications.

Atrium is currently facing hundreds of lawsuits over its popular hernia repair meshes. Injured patients filing the lawsuits claim that the products are defective.

C-QUR Mesh Lawsuits

Patients injured after being implanted with Atrium’s C-QUR mesh are suing Atrium.

More than 2,378 C-QUR hernia mesh lawsuits are pending in New Hampshire federal court. Trials were originally expected to start in 2019, but they were moved to September 2020. In April 2020, Atrium requested that the trial date be moved to January 2021 because of the COVID-19 pandemic.

Injuries alleged in C-QUR mesh lawsuit include:
  • Chronic inflammation or immune/allergic reactions
  • Infections
  • Adhesions
  • Perforation of surrounding tissues
  • Abdominal pain and bowel obstructions
  • Internal tissue degradation caused by mesh erosion
  • Other injuries caused by mesh failure or migration
  • Second surgeries

ProLoop Polypropylene Mesh Lawsuits

A 2014 lawsuit blamed a man’s injuries on Atrium’s ProLoop polypropylene hernia repair mesh.

Juan Paredes of New Jersey filed the lawsuit against Atrium, Maquet and Getinge Group. He accused the hernia mesh manufacturers of designing a faulty device.

Paredes underwent a double inguinal hernia repair in 2011, according to his complaint. Doctors implanted Paredes with the device during the surgery. He had to have a second surgery in 2012 to have it removed.

The lawsuit claims that possible risks attributed to the Atrium ProLoop mesh include:
  • Shrinking, expanding, cracking and deforming
  • Allergic reactions and chronic inflammation
  • Migration
  • Organ damage
  • Nerve damage
  • Chronic pain
  • Sexual dysfunction
Did you suffer serious complications from Atrium's hernia mesh? Get a Free Case Review

Whistleblower Lawsuit Settlement

Atrium settled a whistleblower lawsuit in 2016 for $11.5 million.

Esther Grace Sullivan alleged that Atrium paid illegal kickbacks to doctors. He claimed the company paid doctors to promote the company’s iCast brand medical stents for use in patients’ arteries. The FDA had not approved that use.

Sullivan worked for Atrium from 2007 to 2012. He was a sales representative and territory business manager.

Atrium Settlement
The settlement is one of the largest in U.S. history for claims brought under federal law where the government actually declined to join as a party.

Product Recalls

Atrium has recalled some of its products, including its problematic meshes. The FDA investigated the problems that initiated each mesh recall and recall of other products as well.

Notable Atrium Recalls
  • 2013
    Product Recalled – C-QUR Edge Mesh (all sizes and shapes)

    Reason for Recall – coated mesh can adhere to inner packaging liner with exposure to high humidity conditions
  • 2015
    Product Recalled – Oasis Dry Suction Water Seal Chest Drain

    Reason for Recall – missing o-ring
  • 2018
    Product Recalled – ProLite Mesh (about 60 units)

    Reason for Recall – improper labeling
Atrium Logo
Atrium Medical Facts
  1. Established 1981
  2. Founder Johann Friedrich Fischer (Maquet)
  3. Headquarters Merrimack, New Hampshire
  4. Size 700+ employees
  5. 2017 Revenue About $2.6 billion (Getinge Group)

Please seek the advice of a medical professional before making health care decisions.

Kristin Compton
Written By Kristin Compton Writer

Kristin Compton's background is in legal studies. She worked as a paralegal before joining Drugwatch as a writer and researcher. She was also a member of the National Association of Legal Assistants. A mother and longtime patient, she has firsthand experience of the harmful effects prescription drugs can have on women and their children. Some of her qualifications include:

  • Bachelor of Arts in Legal Studies | Pre-Law from University of West Florida
  • Past employment with The Health Law Firm and Kerrigan, Estess, Rankin, McLeod & Thompson LLC
  • Personal experience battling severe food allergies, asthma and high-risk pregnancies
Edited By
Emily Miller
Emily Miller Managing Editor

16 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. U.S. Food and Drug Administration. (2015, May 7). Class 2 Device Recall Atrium Medical. Retrieved from
  2. U.S. Food and Drug Administration. (2013, July 19). Class 2 Device Recall CQUR Edge Mesh. Retrieved from
  3. Atrium Medical. (2012, April 26). Atrium plans to move headquarters to larger Merrimack, NH facility. Retrieved from
  4. Juan Paredes vs. Atrium Medical Corporation, et al. (2014, March 5). Complaint and Demand For Jury Trial. Case No. 3:14-cv-00499-DMS-DHB. United States District Court, Southern District of California. Retrieved from
  5. U.S. Judicial Panel on Multidistrict Litigation. (2018, June 15). MDL Statistics Report – Distribution of Pending MDL Dockets by District. Retrieved from
  6. Fenske, S. et al. (2017, July 26). Top 30 Global Medical Device Companies. MPO Magazine. Retrieved from
  7. Getinge. (2016, November 3). Mattias Perjos appointed President and CEO of Getinge Group. Retrieved from
  8. Getinge. (n.d). Our history. Retrieved from
  9. Getinge. (n.d.). About Us. Retrieved from
  10. Atrium Maquet Getinge Group. (n.d.). C-Qur Mesh. Retrieved from
  11. Bloomberg LP. (2018, July 9). Company Overview of Atrium Medical Corporation. Retrieved from
  12. Atrium Maquet Getinge Group. (n.d.). Product Status. Retrieved from
  13. Atrium Maquet Getinge Group. (n.d.). About the Consent Decree. Retrieved from
  14. Maquet Cardiovascular. (2011, November 7). Maquet Cardiovascular Completes Acquisition of Atrium Medical Corporation. PR Newswire. Retrieved from
  15. U.S. Judicial Panel on Multidistrict Litigation. (2018, July 16). MDL Statistics Report – Distribution of Pending MDL Dockets by District. Retrieved from
  16. In Re: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation. (2020, April 8). Defendants’ Motion To Extend Deadlines And Trial Date And For Expedited Consideration. Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617